You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 15, 2026

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
Published on: May 13, 2010
Luiza I Hernandez, Isabel Machado, Thomas Schafer
1Biodonostia Research Institute, San Sebastian, Spain. frank.hernandez@biodonostia.org.
Aptamer technology, mature after 25 years, offers diverse applications in diagnostics and therapeutics. These synthetic molecules are rapidly advancing due to interdisciplinary progress in chemistry, nanotechnology, and medicine.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: